TY - JOUR
T1 - Network medicine for disease module identification and drug repurposing with the NeDRex platform
AU - Sadegh, Sepideh
AU - Skelton, James
AU - Anastasi, Elisa
AU - Bernett, Judith
AU - Blumenthal, David B.
AU - Galindez, Gihanna
AU - Salgado-Albarrán, Marisol
AU - Lazareva, Olga
AU - Flanagan, Keith
AU - Cockell, Simon
AU - Nogales, Cristian
AU - Casas, Ana I.
AU - Schmidt, Harald H.H.W.
AU - Baumbach, Jan
AU - Wipat, Anil
AU - Kacprowski, Tim
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Traditional drug discovery faces a severe efficacy crisis. Repurposing of registered drugs provides an alternative with lower costs and faster drug development timelines. However, the data necessary for the identification of disease modules, i.e. pathways and sub-networks describing the mechanisms of complex diseases which contain potential drug targets, are scattered across independent databases. Moreover, existing studies are limited to predictions for specific diseases or non-translational algorithmic approaches. There is an unmet need for adaptable tools allowing biomedical researchers to employ network-based drug repurposing approaches for their individual use cases. We close this gap with NeDRex, an integrative and interactive platform for network-based drug repurposing and disease module discovery. NeDRex integrates ten different data sources covering genes, drugs, drug targets, disease annotations, and their relationships. NeDRex allows for constructing heterogeneous biological networks, mining them for disease modules, prioritizing drugs targeting disease mechanisms, and statistical validation. We demonstrate the utility of NeDRex in five specific use-cases.
AB - Traditional drug discovery faces a severe efficacy crisis. Repurposing of registered drugs provides an alternative with lower costs and faster drug development timelines. However, the data necessary for the identification of disease modules, i.e. pathways and sub-networks describing the mechanisms of complex diseases which contain potential drug targets, are scattered across independent databases. Moreover, existing studies are limited to predictions for specific diseases or non-translational algorithmic approaches. There is an unmet need for adaptable tools allowing biomedical researchers to employ network-based drug repurposing approaches for their individual use cases. We close this gap with NeDRex, an integrative and interactive platform for network-based drug repurposing and disease module discovery. NeDRex integrates ten different data sources covering genes, drugs, drug targets, disease annotations, and their relationships. NeDRex allows for constructing heterogeneous biological networks, mining them for disease modules, prioritizing drugs targeting disease mechanisms, and statistical validation. We demonstrate the utility of NeDRex in five specific use-cases.
UR - http://www.scopus.com/inward/record.url?scp=85119861388&partnerID=8YFLogxK
U2 - 10.1038/s41467-021-27138-2
DO - 10.1038/s41467-021-27138-2
M3 - Article
C2 - 34824199
AN - SCOPUS:85119861388
SN - 2041-1723
VL - 12
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 6848
ER -